Amphastar Pharmaceuticals' (AMPH) Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) Q1 2018 Earnings Conference Call May 9, 2018 5:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray David Maris - Wells Fargo Gary Nachman - BMO Capital Markets David Steinberg - Jefferies Serge Belanger - Needham & Company Operator Good day, ladies and gentlemen, and welcome to the Amphastar First Quarter Earnings Conference Call. At this time all participants are in a listen-only mode. Later we’ll conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. All statements in this conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectations regarding future financial performance, backlog, sales and marketing of its products, market size and growth, the timing of FDA filings or approvals, acquisitions and other matter
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth [Yahoo! Finance]Yahoo! Finance
- Pharvaris appoints David Nassif as chief financial officer [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceAccesswire
AMPH
Earnings
- 2/28/24 - Beat
AMPH
Sec Filings
- 4/19/24 - Form DEFA14A
- 4/12/24 - Form ARS
- 4/12/24 - Form DEFA14A
- AMPH's page on the SEC website